Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of MenB vaccination on meningococcal carriage
2017-004609-42Phase 4Unknown
- Sponsor
- University of Oxford
- Start
- Feb 2018
- Countries
- 1
01
Overview
Phase 4, open-label trial of meningococcal group B vaccine in meningococcal disease (3 cohorts), sponsored by University of Oxford. Primary endpoint: Carriage prevalence of meningococcal genogroups before and after immunization. Status: unknown.
02
Drugs
meningococcal group B vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on 2017-004609-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004609-42.